Viloxazine: A Nonstimulant Treatment Option for ADHD
Researchers compare viloxazine as a nonstimulant treatment option to atomoxetine for managing inattention, hyperactivity, and impulsivity in pediatric and adult patients with ADHD.
Michelle Lampariello
Michelle Lampariello is an assistant editor of The Clinical Advisor at Haymarket Media, Inc. She holds a BA in communication studies from The College of New Jersey. At TCNJ, Michelle was the editor-in-chief of the college's newspaper, The Signal. Before she joined Haymarket in 2020, Michelle completed internships in health communication, magazine writing, and marketing.
